• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白二硫键异构酶 A3(PDIA3):神经胶质瘤的药物靶点?

Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?

机构信息

Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.

出版信息

Int J Mol Sci. 2023 Aug 26;24(17):13279. doi: 10.3390/ijms241713279.

DOI:10.3390/ijms241713279
PMID:37686085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10488224/
Abstract

The protein disulfide isomerase A3 (PDIA3) is directly or indirectly involved in various physiopathological processes and participates in cancer initiation, progression and chemosensitivity. However, little is known about its involvement in glioblastoma. To obtain specific information, we performed cellular experiments in the T98G and U-87 MG glioblastoma cell lines to evaluate the role of PDIA3. The loss of PDIA3 functions, either through inhibition or silencing, reduced glioblastoma cells spreading by triggering cytotoxic phenomena. PDIA3 inhibition led to a redistribution of PDIA3, resulting in the formation of protein aggregates visualized through immunofluorescence staining. Concurrently, cell cycle progression underwent arrest at the G/S checkpoint. After PDIA3 inhibition, ROS-independent DNA damage and the activation of the repair system occurred, as evidenced by the phosphorylation of H2A.X and the overexpression of the Ku70 protein. We also demonstrated through a clonogenic assay that PDIA3 inhibition could increase the chemosensitivity of T98G and U-87 MG cells to the approved glioblastoma drug temozolomide (TMZ). Overall, PDIA3 inhibition induced cytotoxic effects in the analyzed glioblastoma cell lines. Although further in vivo studies are needed, the results suggested PDIA3 as a novel therapeutic target that could also be included in already approved therapies.

摘要

蛋白质二硫键异构酶 A3(PDIA3)直接或间接地参与各种生理病理过程,并参与癌症的发生、发展和化疗敏感性。然而,关于其在神经胶质瘤中的作用知之甚少。为了获得具体信息,我们在 T98G 和 U-87 MG 神经胶质瘤细胞系中进行了细胞实验,以评估 PDIA3 的作用。通过抑制或沉默 PDIA3 的功能,减少神经胶质瘤细胞的扩散,触发细胞毒性现象。PDIA3 抑制导致 PDIA3 的重新分布,导致通过免疫荧光染色可视化的蛋白质聚集体的形成。同时,细胞周期进程在 G/S 检查点停滞。PDIA3 抑制后,发生 ROS 非依赖性 DNA 损伤和修复系统的激活,这表现为 H2A.X 的磷酸化和 Ku70 蛋白的过表达。我们还通过集落形成实验证明,PDIA3 抑制可以增加 T98G 和 U-87 MG 细胞对已批准的神经胶质瘤药物替莫唑胺(TMZ)的化疗敏感性。总体而言,PDIA3 抑制在分析的神经胶质瘤细胞系中诱导细胞毒性作用。尽管还需要进一步的体内研究,但结果表明 PDIA3 是一个新的治疗靶点,也可以包含在已批准的治疗方法中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/738146d5c6fd/ijms-24-13279-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/15da069be64a/ijms-24-13279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/ec248c48abe8/ijms-24-13279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/e7f2e0a6fa4e/ijms-24-13279-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/38720dd80015/ijms-24-13279-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/12dfcd8e0bb3/ijms-24-13279-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/4c517ab95cd8/ijms-24-13279-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/7380f06c0939/ijms-24-13279-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/738146d5c6fd/ijms-24-13279-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/15da069be64a/ijms-24-13279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/ec248c48abe8/ijms-24-13279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/e7f2e0a6fa4e/ijms-24-13279-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/38720dd80015/ijms-24-13279-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/12dfcd8e0bb3/ijms-24-13279-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/4c517ab95cd8/ijms-24-13279-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/7380f06c0939/ijms-24-13279-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e67/10488224/738146d5c6fd/ijms-24-13279-g008.jpg

相似文献

1
Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?蛋白二硫键异构酶 A3(PDIA3):神经胶质瘤的药物靶点?
Int J Mol Sci. 2023 Aug 26;24(17):13279. doi: 10.3390/ijms241713279.
2
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.PDIA3 在胶质母细胞瘤中的表达调节巨噬细胞/小胶质细胞的促肿瘤激活。
Int J Mol Sci. 2020 Nov 3;21(21):8214. doi: 10.3390/ijms21218214.
3
Analysis of Punicalin and Punicalagin Interaction with PDIA3 and PDIA1.分析桔皮素和桔皮苷与 PDIA3 和 PDIA1 的相互作用。
Int J Mol Sci. 2024 Sep 30;25(19):10531. doi: 10.3390/ijms251910531.
4
Impairment of cell adhesion and migration by inhibition of protein disulphide isomerases in three breast cancer cell lines.三种乳腺癌细胞系中,蛋白二硫键异构酶抑制导致细胞黏附与迁移受损。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20193271.
5
Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.蛋白二硫键异构酶 A3 是癌症强有力的预后生物标志物,并能有效预测免疫治疗反应效果。
Front Immunol. 2022 Mar 25;13:837512. doi: 10.3389/fimmu.2022.837512. eCollection 2022.
6
Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.蛋白质二硫键异构酶 A3 表达下调通过 STAT3 信号通路抑制肝癌细胞增殖并诱导细胞凋亡。
Int J Oncol. 2019 Apr;54(4):1409-1421. doi: 10.3892/ijo.2019.4710. Epub 2019 Feb 4.
7
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity.鞣花酸,一种石榴的活性成分,是一种新的 PDIA3 还原酶活性抑制剂。
Biochimie. 2018 Apr;147:122-129. doi: 10.1016/j.biochi.2018.01.008. Epub 2018 Feb 6.
8
Differential expression of protein disulfide-isomerase A3 isoforms, PDIA3 and PDIA3N, in human prostate cancer cell lines representing different stages of prostate cancer.在代表不同前列腺癌阶段的人前列腺癌细胞系中,蛋白质二硫键异构酶 A3 同工型 PDIA3 和 PDIA3N 的差异表达。
Mol Biol Rep. 2021 Mar;48(3):2429-2436. doi: 10.1007/s11033-021-06277-1. Epub 2021 Mar 24.
9
The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.Chk1 抑制剂 SAR-020106 增敏人胶质母细胞瘤细胞对放疗、替莫唑胺和地西他滨治疗的敏感性。
J Exp Clin Cancer Res. 2019 Oct 21;38(1):420. doi: 10.1186/s13046-019-1434-2.
10
Protein disulfide-isomerase A3 knockdown attenuates oxidized low-density lipoprotein-induced oxidative stress, inflammation and endothelial dysfunction in human umbilical vein endothelial cells by downregulating activating transcription factor 2.蛋白二硫键异构酶 A3 敲低通过下调激活转录因子 2 减轻氧化型低密度脂蛋白诱导的人脐静脉内皮细胞氧化应激、炎症和内皮功能障碍。
Bioengineered. 2022 Jan;13(1):1436-1446. doi: 10.1080/21655979.2021.2018980.

引用本文的文献

1
Analysis of Punicalin and Punicalagin Interaction with PDIA3 and PDIA1.分析桔皮素和桔皮苷与 PDIA3 和 PDIA1 的相互作用。
Int J Mol Sci. 2024 Sep 30;25(19):10531. doi: 10.3390/ijms251910531.
2
Suppressing ERp57 diminishes osteoclast activity and ameliorates ovariectomy-induced bone loss via the intervention in calcium oscillation and the calmodulin/calcineurin/Nfatc1 pathway.抑制内质网蛋白57可通过干预钙振荡以及钙调蛋白/钙调神经磷酸酶/活化T细胞核因子c1通路来降低破骨细胞活性,并改善卵巢切除诱导的骨质流失。
Heliyon. 2024 Jul 27;10(15):e35374. doi: 10.1016/j.heliyon.2024.e35374. eCollection 2024 Aug 15.
3
The Versatility of Collagen in Pharmacology: Targeting Collagen, Targeting with Collagen.

本文引用的文献

1
Tumor microenvironment in glioblastoma: Current and emerging concepts.胶质母细胞瘤中的肿瘤微环境:当前及新出现的概念
Neurooncol Adv. 2023 Feb 23;5(1):vdad009. doi: 10.1093/noajnl/vdad009. eCollection 2023 Jan-Dec.
2
Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma.使用白蛋白包裹的纳米粒靶向未折叠蛋白反应可减轻胶质母细胞瘤对替莫唑胺的耐药性。
Br J Cancer. 2023 May;128(10):1955-1963. doi: 10.1038/s41416-023-02225-x. Epub 2023 Mar 17.
3
Inhibition of Protein Disulfide Isomerase (PDIA1) Leads to Proteasome-Mediated Degradation of Ubiquitin-like PHD and RING Finger Domain-Containing Protein 1 (UHRF1) and Increased Sensitivity of Glioblastoma Cells to Topoisomerase II Inhibitors.
胶原蛋白在药理学中的多功能性:靶向胶原蛋白,用胶原蛋白靶向。
Int J Mol Sci. 2024 Jun 13;25(12):6523. doi: 10.3390/ijms25126523.
4
Changes Induced by P2X7 Receptor Stimulation of Human Glioblastoma Stem Cells in the Proteome of Extracellular Vesicles Isolated from Their Secretome.P2X7 受体刺激人神经胶质瘤干细胞对其分泌组来源的细胞外囊泡蛋白质组的影响。
Cells. 2024 Mar 25;13(7):571. doi: 10.3390/cells13070571.
抑制蛋白二硫键异构酶(PDIA1)导致蛋白酶体介导的含泛素样PHD和环指结构域蛋白1(UHRF1)降解,并增加胶质母细胞瘤细胞对拓扑异构酶II抑制剂的敏感性。
ACS Pharmacol Transl Sci. 2022 Dec 7;6(1):100-114. doi: 10.1021/acsptsci.2c00186. eCollection 2023 Jan 13.
4
Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.泛癌分析 PDIA3:鉴定其为肿瘤预后和免疫治疗的潜在生物标志物。
Oxid Med Cell Longev. 2022 Aug 22;2022:9614819. doi: 10.1155/2022/9614819. eCollection 2022.
5
Comparison of anti-cancer effects of novel protein disulphide isomerase (PDI) inhibitors in breast cancer cells characterized by high and low PDIA17 expression.新型蛋白质二硫键异构酶(PDI)抑制剂对高表达和低表达PDIA17的乳腺癌细胞抗癌作用的比较。
Cancer Cell Int. 2022 Jun 20;22(1):218. doi: 10.1186/s12935-022-02631-w.
6
Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.蛋白二硫键异构酶 A3 是癌症强有力的预后生物标志物,并能有效预测免疫治疗反应效果。
Front Immunol. 2022 Mar 25;13:837512. doi: 10.3389/fimmu.2022.837512. eCollection 2022.
7
ERp57/PDIA3: new insight.ERp57/PDIA3:新的见解。
Cell Mol Biol Lett. 2022 Feb 2;27(1):12. doi: 10.1186/s11658-022-00315-x.
8
A Novel Circular RNA CircRFX3 Serves as a Sponge for MicroRNA-587 in Promoting Glioblastoma Progression via Regulating PDIA3.一种新型环状RNA CircRFX3通过调控PDIA3作为微小RNA-587的海绵,促进胶质母细胞瘤进展。
Front Cell Dev Biol. 2021 Dec 7;9:757260. doi: 10.3389/fcell.2021.757260. eCollection 2021.
9
Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis.蛋白二硫键异构酶 A3 的突变通过扰乱内质网的蛋白质平衡引起神经发育缺陷。
EMBO J. 2022 Dec 17;41(2):e105531. doi: 10.15252/embj.2020105531. Epub 2021 Dec 14.
10
A Comparative Analysis of Punicalagin Interaction with PDIA1 and PDIA3 by Biochemical and Computational Approaches.通过生化和计算方法对石榴皮素与PDIA1和PDIA3相互作用的比较分析
Biomedicines. 2021 Oct 25;9(11):1533. doi: 10.3390/biomedicines9111533.